Research Institute for Genetic and Human Therapy Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
1999
NCT00002427
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (3)

didanosine (videx) (1 trial)

hydroxyurea (hydrea) (1 trial)

stavudine (zerit) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 1)

HIV Infections (Phase 1)

Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 3